Program Overview 

The Fifth Annual Medical, Interventional, Surgical IBD Symposium will bring together leading experts in gastroenterology, surgery, and interventional medicine to explore the latest advancements in the management and treatment of inflammatory bowel disease (IBD). This one-day, CME-accredited event will focus on medical therapies, diagnostic challenges, IBD mimics, complications, and surgical interventions. The program will feature lectures from renowned specialists, followed by a case discussion session to provide practical insights into complex clinical scenarios. The symposium is structured to provide in-depth knowledge and updates on the current state of IBD therapies, including biologics, small molecular agents, and endoscopic treatments. Experts will also present strategies for managing IBD complications, such as cancer risks and postoperative monitoring. The interactive case discussions will offer participants an opportunity to engage with the panel of experts to review real-world clinical cases.

Learning Objectives:

• Understand and apply the latest advancements in medical therapies for IBD, including anti-IL23 therapy, anti-TNF therapy, and small-molecule agents, to optimize patient outcomes.
• Evaluate and manage the diagnostic challenges of IBD, including differentiating IBD from IBD mimics and identifying complications such as adenocarcinoma and squamous cell carcinoma in IBD patients.
• Assess and develop individualized surgical treatment plans for IBD patients, including postoperative monitoring, endoscopic therapy, and the appropriate use of surgical interventions in Crohn’s disease and ulcerative colitis.

Target Audience

This program has been designed for regional, national, and worldwide audiences, including gastroenterologists, inflammatory bowel disease specialists, GI endoscopists, colorectal surgeons, general surgeons, GI pathologists, GI radiologists, NP/PA/RN in gastroenterology, IBD, and colorectal surgery, stoma nurses, medical students, medical/surgical residents, and GI/colorectal fellows.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Columbia University Department of Surgery and Amedco LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.